These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2442093)

  • 1. Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factor.
    Fendly BM; Toy KJ; Creasey AA; Vitt CR; Larrick JW; Yamamoto R; Lin LS
    Hybridoma; 1987 Aug; 6(4):359-70. PubMed ID: 2442093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF).
    Meager A; Parti S; Leung H; Peil E; Mahon B
    Hybridoma; 1987 Jun; 6(3):305-11. PubMed ID: 2439440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four epitopes on tumor necrosis factor-alpha defined by murine anti-tumor necrosis factor-alpha monoclonal antibodies.
    Karim B; Béliard R; Huart JJ; Bourel D
    Immunol Lett; 1994 Jul; 41(2-3):139-45. PubMed ID: 8002029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional properties of cooperative monoclonal antibodies against human tumor necrosis factor].
    Vodianyk MO; Chernyshov VP; Humeniuk MIe
    Fiziol Zh (1994); 2001; 47(3):73-9. PubMed ID: 11519254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody.
    Corti A; Bagnasco L; Cassani G
    Lymphokine Cytokine Res; 1994 Jun; 13(3):183-90. PubMed ID: 7524695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of monoclonal antibodies to human tumor necrosis factor.
    Hirai M; Okamura N; Terano Y; Tsujimoto M; Nakazato H
    J Immunol Methods; 1987 Jan; 96(1):57-62. PubMed ID: 3805735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
    Sheehan KC; Ruddle NH; Schreiber RD
    J Immunol; 1989 Jun; 142(11):3884-93. PubMed ID: 2469726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to the E1 and E2 glycoproteins of Sindbis virus: definition of epitopes and efficiency of protection from fatal encephalitis.
    Mendoza QP; Stanley J; Griffin DE
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3015-22. PubMed ID: 2462014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic structure of human tumour necrosis factor: recognition of distinct regions of TNF alpha by different tumour cell receptors.
    Rathjen DA; Cowan K; Furphy LJ; Aston R
    Mol Immunol; 1991; 28(1-2):79-86. PubMed ID: 1707138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.
    Rutka JT; Giblin JR; Berens ME; Bar-Shiva E; Tokuda K; McCulloch JR; Rosenblum ML; Eessalu TE; Aggarwal BB; Bodell WJ
    Int J Cancer; 1988 Apr; 41(4):573-82. PubMed ID: 2833452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping and functional analysis of three murine IgG1 monoclonal antibodies to human tumor necrosis factor-alpha.
    Bloom JW; Bettencourt JD; Mitra G
    J Immunol; 1993 Sep; 151(5):2707-16. PubMed ID: 7689613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody.
    Lucas R; Heirwegh K; Neirynck A; Remels L; Van Heuverswyn H; De Baetselier P
    Immunology; 1990 Oct; 71(2):218-23. PubMed ID: 2228022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNF alpha).
    McLaughlin PJ; Elwood NJ; Russell SM; Andrew SM; McKenzie IF
    Anticancer Res; 1992; 12(4):1243-6. PubMed ID: 1503416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
    Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G
    Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of monoclonal antibodies to ovine tumor necrosis factor-alpha and development of a sensitive immunoassay.
    Egan PJ; Rothel JS; Andrews AE; Seow HF; Wood PR; Nash AD
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):259-74. PubMed ID: 7941307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor.
    Shieh JH; Peterson RH; Warren DJ; Moore MA
    J Immunol; 1989 Oct; 143(8):2534-9. PubMed ID: 2551961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.